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Two strikes lead to leukemia
 
New genetic mapping studies explain 
why a certain mouse strain is predisposed 
to developing fatal leukemia. Turcotte et 
al., reporting on page 881, identify a 
point mutation in the transcription factor 
IRF-8 (interferon regulatory factor 8) 
that abolishes its function and sets the 
stage for a second, leukemia-triggering 
mutation.
The recombinant mouse strain BXH-2 is 
known to develop first a myeloproliferative 
disease characterized by enlarged spleens 
with excess granulocytes, and later a 
 
Defenseless against the common cold
 
Epithelial cell dysfunction may explain why people with
asthma fare worse than most when infected with common
cold viruses. Wark and colleagues show on page 937 that
bronchial epithelial cells from asthma sufferers fail to invoke
critical antiviral defenses but still provoke inflammation when
infected with rhinoviruses—an ideal combination for asthma
induction.
Respiratory virus infections often trigger asthma attacks, and
these infections are more severe in asthma sufferers than in
healthy individuals. Past studies have demonstrated increased vi-
rus replication in asthmatic versus healthy subjects and suggested
that alterations in cytokine production that favor asthma-
promoting T helper (Th)-2 responses might be to blame.
Wark and colleagues now uncover a defect that may pro-
vide the initial trigger for virus-induced asthma. They
found that bronchial epithelial cells—the primary targets of
 
spontaneous, fatal myeloid leukemia. The 
myeloproliferative disease is associated 
with a mutation at the 
 
Myls
 
 locus on 
chromosome 8, and the leukemia with 
insertion of an endogenous murine 
leukemia virus (MuLV) into host tumor 
suppressor genes.
The offending virus arises from a 
recombination event between two 
innocuous MuLV proviruses; they are 
carried in the genome of BXH mice but, 
before recombination, cannot produce 
replicating virus progeny. Eager to 
understand how the viral integration 
event was connected to the 
 
Myls
 
 locus, 
Turcotte and colleagues scoured the 
locus for genetic clues. Their search 
revealed an inactivating point mutation 
in IRF-8, a transcription factor that 
regulates interferon-responsive genes. 
The mutation was found only in strains 
that are susceptible to getting leukemia.
The IRF-8 mutation explained the 
myeloproliferative disease in the BXH-2 
mice, as IRF-8–deficient mice were 
previously shown to have a similar 
phenotype. IRF-8–deficient mice also 
develop leukemia, but it is not as rapid 
or as severe as in BXH-2 mice, perhaps 
because these strains lack the MuLV 
proviruses. The authors think that the 
absence of IRF-8 is only the first hit in 
leukemia development. The excess cell 
division and faulty immune response 
caused by the loss of IRF-8, they 
suggest, must promote recombination 
that generates a replication-competent 
MuLV retrovirus that can then insert 
into the host genome.
This may be a good model for human 
chronic myeloid leukemia (CML), which 
progresses from a chronic phase 
involving granulocytes to a rapidly fatal 
crisis stage. The authors are now looking 
for the homologue of IRF-8 in human 
CML tumors.
A mutation in IRF-8 causes myeloproliferation in the spleen which predisposes BXH-2 
mice to leukemia.
 
viral infection—from asthma sufferers supported more virus
replication than did cells from healthy controls. The reason
for this was twofold: epithelial cells from asthmatic subjects
failed to produce the potent anti-viral cytokine interferon-
 
 
 
(IFN-
 
 
 
) and also failed to initiate apoptosis, mechanisms
employed by healthy cells to limit virus replication and elimi-
nate infected cells. These defects may be linked, as IFN-
 
 
 
 was
recently shown to induce apoptosis in virus-infected cells.
How does this enhanced viral replication lead to asthma?
The authors show that epithelial cells from asthma sufferers,
although unable to produce IFN-
 
 
 
, could still secrete pro-
inflammatory cytokines, which can recruit asthma-inducing
eosinophils and Th2 cells to the lungs. Future experiments
are planned to identify the mutation that causes the IFN-
 
 
 
defect. Although several genetic markers have been linked to
asthma in the past, so far none are related to IFNs.
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